Multimodality Treatments in Metastatic Gastric Cancer

• Altres autors: Petrillo, Angelica (Editor)
• Format: Electrònic Capítol de llibre
• Idioma: anglès
• Publicat: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
• Matèries: Medicine; advanced gastric cancer; precision medicine; new drug development; gastro-oesophageal cancer; mutational concordance; exome sequencing; formalin fixed paraffin embedded; biomarkers; gastric cancer; metastatic; body composition; sarcopenia; visceral fat area; subcutaneous fat area; outcome; toxicity; liver metastasis; conversion surgery; hepatectomy; stage iv gastric cancer; immune checkpoint inhibitors; Epstein Barr Virus; tumor mutational burden; microsatellite instability; predictive biomarkers; CAR T cell therapy; vaccines; nutritional status; metastatic gastric cancer; target therapy; bone flare; stage IV; treatment; RANK-L; liquid biopsy; circulating tumor cell; cfDNA; ctDNA; epithelial-mesenchymal transition; resistance to treatment; HER2-inhibition; VEGFR-inhibition; immunotherapy; response monitoring; n/a
• Accés en línia: DOAB: download the publication; DOAB: description of the publication

Gastric cancer represents one of the most frequent and lethal tumors worldwide today, finding itself in the fifth place in incidence and the third in mortality. Surgery remains the only curative treatment for localized tumors, but only 20% of patients are suitable for surgery due to the lack of spec...